Witnessing the stock’s movement on the chart, on Thursday, Integra Lifesciences Holdings Corp (NASDAQ: IART) set off with pace as it heaved 0.31% to $23.00, before settling in for the price of $22.93 at the close. Taking a more long-term approach, IART posted a 52-week range of $16.81-$45.42.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 1.17%. Meanwhile, its Annual Earning per share during the time was 3.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -20.93%. This publicly-traded company’s shares outstanding now amounts to $78.17 million, simultaneously with a float of $66.18 million. The organization now has a market capitalization sitting at $1.77 billion. At the time of writing, stock’s 50-day Moving Average stood at $19.96, while the 200-day Moving Average is $27.45.
Integra Lifesciences Holdings Corp (IART) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Devices industry. Integra Lifesciences Holdings Corp’s current insider ownership accounts for 14.24%, in contrast to 92.97% institutional ownership. According to the most recent insider trade that took place on Aug 19 ’24, this organization’s SVP, Fin & Princ Acct Officer sold 1,191 shares at the rate of 21.58, making the entire transaction reach 25,701 in total value, affecting insider ownership by 36,088. Preceding that transaction, on May 23 ’24, Company’s Exec. Chairman of the Board bought 52,641 for 28.49, making the whole transaction’s value amount to 1,499,979. This particular insider is now the holder of 487,922 in total.
Integra Lifesciences Holdings Corp (IART) Earnings and Revenue Records
Integra Lifesciences Holdings Corp’s EPS decrease for this current 12-month fiscal period is -20.93% and is forecasted to reach 2.51 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -3.71% through the next 5 years, which can be compared against the 3.10% growth it accomplished over the previous five years trading on the market.
Integra Lifesciences Holdings Corp (NASDAQ: IART) Trading Performance Indicators
Let’s observe the current performance indicators for Integra Lifesciences Holdings Corp (IART). It’s Quick Ratio in the last reported quarter now stands at 0.73. The Stock has managed to achieve an average true range (ATR) of 1.01. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.13. Similarly, its price to free cash flow for trailing twelve months is now 46.66.
In the same vein, IART’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.09, a figure that is expected to reach 0.85 in the next quarter, and analysts are predicting that it will be 2.51 at the market close of one year from today.
Technical Analysis of Integra Lifesciences Holdings Corp (IART)
Going through the that latest performance of [Integra Lifesciences Holdings Corp, IART]. Its last 5-days volume of 1.02 million was inferior to the volume of 1.1 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 22.60% While, its Average True Range was 1.00.
Raw Stochastic average of Integra Lifesciences Holdings Corp (IART) in the period of the previous 100 days is set at 39.07%, which indicates a major rise in contrast to 27.76% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 106.07% that was higher than 62.47% volatility it exhibited in the past 100-days period.
